NCT04787146

File Analysis of Falling Patients: Are Drugs Frequently Involved

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 52 (actual)
• Sponsor: Fondation Hôpital Saint-Joseph · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The damage caused by patient falls is a major public health problem, due to the large and growing number of people concerned, the potentially serious consequences but also the financial cost generated by their care. These consequences can be physical as well as psychological. Fractures and pain are the first consequences that come to mind, but many others should be mentioned: post-fall syndrome, loss of autonomy or even entering an institution, fear of falling, loss of confidence in itself.

Detailed description

During 2018, 285 reports of falls were counted within the Paris Saint-Joseph Hospital Group (GhPSJ). Reducing these falls is one of the institutional goals. A dedicated working group has been created to put in place preventive and corrective measures. These falls can be caused by many factors to the patient: 1. Intrinsic: * History of a fall, * pathologies (Parkinson's or Alzheimer's disease), * hearing and visual disturbances, * urinary incontinence. 2. extrinsic: * Unsuitable shoes * unsuitable habitat, * slippery floors (eg bathroom). Among the intrinsic factors, polypharmacy is also found. It has been established that certain drug classes are at risk of falling, in particular psychotropic drugs (benzodiazepines, hypnotics, anxiolytics, antidepressants, neuroleptics) which promote sedation and dizziness, hypoglycemic drugs which cause hypoglycaemia in diabetic patients on -treated or antihypertensive drugs causing hypotension. It is now clearly established that drug adherence to treatment is poor in cities, giving rise to omissions but also sometimes to overconsumption of certain drugs, including psychotropic drugs.

Conditions

• Fall Patients

Interventions

Type	Name	Description
OTHER	No intervention	Once the patient is included, a drug assessment is carried out as part of the treatment and then an compliance questionnaire is submitted to him.

Timeline

• Start date: 2019-04-18
• Primary completion: 2019-10-15
• Completion: 2021-02-28
• First posted: 2021-03-08
• Last updated: 2021-03-08

Locations

1 site across 1 country: France